A New Test for the Detection of Direct Oral Anticoagulants (Rivaroxaban and Apixaban) in the Emergency Room Setting
Determining whether a patient has taken a direct oral anticoagulant (DOAC) is critical during the periprocedural and preoperative period in the emergency department. However, the inaccessibility of complete medical records, along with the generally inconsistent sensitivity of conventional coagulatio...
Main Authors: | Frydman, Galit H., Ellett, Felix, Van Cott, Elizabeth M., Hayden, Douglas, Majmudar, Maulik, Vanderburg, Charles R., Dalzell, Haley, Padmanabhan, Divya L., Davis, Nick, Jorgensen, Julianne, Toner, Mehmet, Fox, James G, Tompkins, Ronald G. |
---|---|
Other Authors: | Massachusetts Institute of Technology. Division of Comparative Medicine |
Format: | Article |
Language: | English |
Published: |
Ovid Technologies (Wolters Kluwer Health)
2020
|
Online Access: | https://hdl.handle.net/1721.1/128674 |
Similar Items
-
Evaluation of the Determination of Dabigatran, Rivaroxaban, and Apixaban in Lupus Anticoagulant-Positive Patients
by: Jana Úlehlová, et al.
Published: (2021-11-01) -
A review of pharmacogenetics of anticoagulant therapy: Heparins, rivaroxaban, apixaban, and dabigatran
by: Ali Mohammed Abd Alridha, et al.
Published: (2022-01-01) -
Measurement of Anticoagulation in Patients on Dabigatran, Rivaroxaban, and Apixaban Therapy by Novel Automated Thrombelastography
by: Ramin Artang, et al.
Published: (2021-10-01) -
Comparison of peri-procedural anticoagulation with rivaroxaban and apixaban during radiofrequency ablation of atrial fibrillation
by: Jayasree Pillarisetti, et al.
Published: (2020-11-01) -
Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
by: Antonijević Nebojša, et al.
Published: (2020-01-01)